SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-067835
Filing Date
2019-03-08
Accepted
2019-03-08 06:04:02
Documents
4
Period of Report
2019-03-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d720446d8k.htm 8-K 26903
2 EX-99.1 d720446dex991.htm EX-99.1 13694
3 GRAPHIC g720446g0308105452447.jpg GRAPHIC 4624
4 GRAPHIC g720446img2.jpg GRAPHIC 11677
  Complete submission text file 0001193125-19-067835.txt   64717
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32587 | Film No.: 19667502
SIC: 2834 Pharmaceutical Preparations